Cost-Minimization Analysis of Linagliptin Compared to Sitagliptin in the Treatment of Type 2 Diabetes Mellitus From a Turkish Healthcare Perspective
Journal of Diabetes & Metabolism
doi 10.4172/2155-6156.1000739
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
OMICS Publishing Group